|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
BRCA1 and BRCA2 Analysis Panel
MessageTest cost $2200
This test is currently only available in BHS CPRS. If you are a Bedford provider and wish to see this test offered in Bedford CPRS- please contact the Bedford Laboratory.
This test is currently only available in BHS CPRS. If you are a Bedford provider and wish to see this test offered in Bedford CPRS- please contact the Bedford Laboratory.
Test Code
BRCA1 AND BRCA2 ANALYSIS PANEL
Alias/See Also
BRAC
HBOC
Hereditary breast-ovarian cancer syndrome
HBOC
Hereditary breast-ovarian cancer syndrome
Preferred Specimen
6 Purple top tubes, whole blood
Instructions
Wait at least two weeks after a packed cell or platelet transfusion and at least four weeks after a whole blood transfusion prior to blood draw.
Transport Temperature
Room Temperature
Specimen Stability
Refrigerated
DO NOT FREEZE!
DO NOT FREEZE!
Methodology
Deletion/Duplication Analysis, Gene Sequence Analysis, Specific Site Analysis
Report Available
< 14 days
Reference Range
Provided with the patient report in CPRS.
Clinical Significance
Hereditary breast-ovarian cancer (HBOC) syndrome is an autosomal dominant cancer predisposition syndrome caused by germline BRCA1/2 mutations. Mutations in these two highly penetrant genes increase the chance for cancer of the breast, ovaries and fallopian tubes, pancreas and prostate.3 Studies suggest female BRCA1 mutation carriers have between a 57-87% risk to develop breast cancer and between a 39-40% risk to develop ovarian cancer by age 70. Similarly male BRCA1 mutation carriers have a cumulative breast cancer risk of 1.2% by age 70.
Performing Laboratory
Test performed at Ambry Genetics and transported via Quest.
Additional Information
Link to test information on AmbryGenetics website
Last Updated: November 3, 2015